IL‐38 can significantly downregulate the expression of IL‐1β and TNF‐α released by lipopolysaccharide‐stimulated macrophages,29 indicating that IL‐38 may exert therapeutic effects on AD via suppressing neuroinflammation, however, the underlying mechanism needs to be further investigated. The gene discussed is IL1F10; the disease is Alzheimer disease.